F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
45.33
-0.04 (-0.09%)
At close: Sep 11, 2026, 4:00 PM EDT
45.27
-0.06 (-0.13%)
After-hours: Sep 11, 2026, 7:30 PM EDT
LFSC Holdings Information
LFSC is an equity ETF with a total of 40 individual holdings. The top holdings are Travere Therapeutics stock at 8.43%, Spyre Therapeutics at 7.58%, Cogent Biosciences at 7.01%, LivaNova at 6.50%, and Corcept Therapeutics at 6.46%.
Total Holdings
40
Top 10 Percentage
56.66%
Asset Class
Equity
ETF Category
Health
Assets
127.64M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 8.43% |
| 2 | SYRE | Spyre Therapeutics, Inc. | 7.58% |
| 3 | COGT | Cogent Biosciences, Inc. | 7.01% |
| 4 | LIVN | LivaNova PLC | 6.50% |
| 5 | CORT | Corcept Therapeutics Incorporated | 6.46% |
| 6 | GH | Guardant Health, Inc. | 5.86% |
| 7 | MIRM | Mirum Pharmaceuticals, Inc. | 4.67% |
| 8 | CYTK | Cytokinetics, Incorporated | 3.62% |
| 9 | BLLN | BillionToOne, Inc. | 3.34% |
| 10 | AXSM | Axsome Therapeutics, Inc. | 3.20% |
| 11 | UTHR | United Therapeutics Corporation | 3.19% |
| 12 | MANE | Veradermics, Incorporated | 3.08% |
| 13 | NKTR | Nektar Therapeutics | 3.07% |
| 14 | SVRA | Savara Inc. | 2.95% |
| 15 | TMDX | TransMedics Group, Inc. | 2.90% |
| 16 | DNTH | Dianthus Therapeutics, Inc. | 2.79% |
| 17 | TRVI | Trevi Therapeutics, Inc. | 2.68% |
| 18 | VRDN | Viridian Therapeutics, Inc. | 2.42% |
| 19 | ICUI | ICU Medical, Inc. | 2.31% |
| 20 | PVLA | Palvella Therapeutics, Inc. | 2.13% |
| 21 | CRVS | Corvus Pharmaceuticals, Inc. | 1.98% |
| 22 | TWST | Twist Bioscience Corporation | 1.78% |
| 23 | CBLL | CeriBell, Inc. | 1.61% |
| 24 | HNGE | Hinge Health, Inc. | 1.21% |
| 25 | GMED | Globus Medical, Inc. | 1.11% |
As of Aug 12, 2026